According to the national cancer registration business annual report (2021 cancer registration statistics), the five-year ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Pancreatic cancer is often diagnosed late due to its hidden location and lack of early symptoms. Vague symptoms like weight loss and back pain often lead to delayed diagnosis. While anyone can ...

Recent advances in immunotherapy research have revealed crucial roles for new immune cells in combating cancer, leading to ...

T1 Tumor limited to the pancreas and size <2 cm T2 Tumor limited to the pancreas and size 2–4 cm T3 Tumor limited to the pancreas and size >4 cm or invading duodenum or bile duct T4 Tumor ...

Background and Aim: Intraductal papillary mucinous tumor (IPMT) of the pancreas can be divided into three clinically distinct subtypes: main duct type, branch duct type and mixed type. Although it ...

Before Exelexis’ Cabometyx can pass muster with the FDA in its hopeful neuroendocrine tumors indication next April, it will ...

Before I underwent surgery to remove tumors on several organs, I was told it was the only way to determine what cancer I had.

High-Dose IV Vitamin C Plus Chemotherapy Doubles Survival in Advanced Pancreatic Cancer Nov. 18, 2024 — A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV ...

DELHI, DELHI, INDIA, November 28, 2024 /EINPresswire / -- The Growth of the KRAS Inhibitors Market is expected to be mainly driven by increasing incidence, a rise in awareness and access to treatment, ...

Indication, Study Design, Indication by Study Design, Sponsor, Service and Segment Forecasts U.S. Clinical Trials Market U.S.

Verastem's promising progress in RAS-driven cancers, potential FDA approval, and growth opportunities present a bullish ...